Announcements Trials
Browse Landscape

Phase

Phase 2 38Phase 1 13Phase 1/2 8Phase 3 3Phase NA 1Phase 4 1Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Warts 1Recurrence 1Neutropenia 1Multiple Myeloma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia 1Infections 1Immunologic Deficiency Syndromes 1Hodgkin Disease 1Hematologic Neoplasms 1Febrile Neutropenia 1Congenital Abnormalities 1Breast Neoplasms 1Agammaglobulinemia 1

Interventions

Cyclophosphamide 11Cytarabine 8Methotrexate 6Etoposide 6Dexamethasone 6Vincristine 5Radiotherapy 5Doxorubicin 5Daunorubicin 5pegaspargase 4Trimethoprim, Sulfamethoxazole Drug Combination 4Mercaptopurine 4Idarubicin 4gamma-Globulins 3fludarabine phosphate 3Whole-Body Irradiation 3Prednisone 3N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3Methylprednisolone 3Gemtuzumab 3Filgrastim 3Clofarabine 3Ciprofloxacin 3Busulfan 3etoposide phosphate 2blinatumomab 2Thioguanine 2Melphalan 2Karyotyping 2Injections, Spinal 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Leukemia × Granulocyte Colony-Stimulating Factor × Clear all
NCT00630565 2024-01-29

Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

Masonic Cancer Center, University of Minnesota

Phase 2/3 Terminated
12 enrolled 12 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡